This is a test. Please DO NOT submit. α ∨ β
ID: 350750Type: Posted
Overview

Buyer

IV&V Test Agency (IVV)

Award Range

$1 - $2

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Other

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350750
Timeline
    Description

    The IV&V Test Agency has posted a federal grant opportunity titled "This is a test. Please DO NOT submit." This grant does not require cost sharing or matching and is categorized under "Other" funding activities, with an award ceiling of $2 and an award floor of $1. Although the details are primarily for testing purposes, the opportunity is open to a broad range of eligible applicants. Interested parties should note that the grantor contact email is Test@hhs.gov, but they are advised not to reach out. The opportunity was last updated on October 26, 2023, and further details can be found under the CFDA number 00.000.

    Point(s) of Contact
    Test@hhs.gov
    Files
    No associated files provided.
    Similar Opportunities
    IVV S2S Testing - Do not submit
    Active
    IV&V Test Agency
    The IV&V Test Agency has announced a federal grant opportunity titled "IVV S2S Testing - Do not submit," aimed at supporting specific testing initiatives within the health category. This opportunity is designated for IVV testing only, and applicants are advised not to submit proposals as it is not open for submissions. The grant does not require cost sharing or matching and has a funding instrument type classified as "Other," with an award ceiling and floor set at $1. The application period will close on November 1, 2025, and interested parties can reach out to Bhavna Ramachandran at bhavna.ramachandran@bpsconsulting.com for further information.
    Test Opportunity
    Active
    IV&V Test Agency
    The IV&V Test Agency is offering a federal grant opportunity titled "Test Opportunity," aimed at supporting city or township governments in the field of agriculture. This discretionary grant does not require cost sharing or matching funds, allowing eligible applicants to focus on their project objectives without financial constraints. The grant is intended to facilitate initiatives that contribute to agricultural development, although specific project details are not provided in the overview. Interested applicants should note that the application deadline is June 27, 2050, and can reach out to the grantor at test.grantor01@mailinator.com for further inquiries.
    PTS-SB-SYNP01
    Active
    IV&V Test Agency
    The IV&V Test Agency has announced a federal grant opportunity titled "PTS-SB-SYNP01," aimed at supporting community development initiatives. This grant does not require cost sharing or matching and is open to unrestricted applicants, allowing a wide range of organizations to participate. The funding instrument offers an award ceiling of $10 million and a floor of $1 million, emphasizing the importance of substantial financial support for community-focused projects. Interested applicants should note that the application deadline is November 30, 2030, and can reach out to the grantor at test.grantor01@mailinator.com or by phone at 123-456-7890 for further inquiries.
    What is a grant? A grant is a way the government funds your ideas and projects to provide public services and stimulate the economy. Grants support critical recovery initiatives, innovative research, and many other programs listed in the Catalog of Feder!
    Active
    IV&V Test Agency
    The IV&V Test Agency is forecasting a federal grant opportunity aimed at funding innovative projects that provide public services and stimulate the economy, particularly in the agriculture sector. This grant, categorized as an earmark, will be awarded through a cooperative agreement, with no cost-sharing or matching requirements for eligible applicants, which include city or township governments. The initiative is part of broader recovery efforts and supports critical research and programs listed in the Catalog of Federal Domestic Assistance (CFDA). Interested applicants can reach out to Test Grantor Grantor at test.grantor01@mailinator.com or call 123-456-7890 for further information. The opportunity is set for the fiscal year 2023, with the last update provided on October 27, 2023.
    TEST FORECAST
    Active
    DOT Federal Highway Administration
    The Department of Transportation's Federal Highway Administration is forecasting a grant opportunity titled "TEST FORECAST" aimed at supporting transportation-related initiatives. This discretionary grant does not require cost sharing or matching and is specifically available to state governments, with a focus on enhancing transportation infrastructure and services. The funding, categorized under CFDA number 20.200, is anticipated for the fiscal year 2024, and interested applicants can reach out to the Agreement Officer at agreement.officer@dot.gov or by phone at 202-366-0000 for further details.
    Test Forcast
    Active
    Air Force Office of Scientific Research
    The Air Force Office of Scientific Research (AFOSR) is forecasting a grant opportunity titled "Test Forecast" aimed at advancing science and technology through research and development initiatives. This grant does not require cost sharing or matching and is open to a variety of eligible applicants, with a total of 12 awards expected to be made. The opportunity is significant for fostering innovative research that aligns with the objectives of the Department of Defense. Interested applicants can reach out to Calvin D. Scott at calvin.scott@us.af.mil or by phone at 999-999-9999 for further details, with the synopsis expected to be posted on February 28, 2024.
    FOUNDATIONS OF TRUSTED SYSTEMS
    Active
    Air Force -- Research Lab
    The Air Force Research Lab is offering a federal grant opportunity titled "Foundations of Trusted Systems," aimed at advancing research and development in science and technology. This grant seeks to support innovative projects that enhance the reliability and security of systems, with no cost-sharing or matching requirements for applicants. The funding amount has an award ceiling of $99,900,000, reflecting the significant investment in fostering cutting-edge research in this critical area. Interested applicants can find additional eligibility information and submit inquiries to Kenneth R. Gigliotti at AFRL.RIKA.Support@us.af.mil, with the application deadline set for December 5, 2028.
    Biological Testing Facility (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Biological Testing Facility (X01 Clinical Trial Not Allowed)" aimed at advancing contraceptive development programs through the provision of specialized services. This funding opportunity announcement (FOA) is designed to support innovative and validated methods that are essential for future clinical development, allowing applicants who may not currently hold NIH funding to apply, although priority may be given to those with existing NIH support. The grant is categorized under Income Security and Social Services, with no cost-sharing or matching requirements, and is open to a diverse range of eligible applicants, including various educational institutions and organizations. Interested parties should note that the application deadline is May 2, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-128.html.
    Biological Testing Facility (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Biological Testing Facility (X01 Clinical Trial Not Allowed)" aimed at supporting research in the development of non-hormonal contraceptive methods. This grant allows investigators to access the Biological Testing Facility (BTF) for preclinical studies and Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies, with a focus on advancing contraceptive development to address unintended pregnancies in the U.S. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and foreign entities, with applications due by May 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-192.html.
    NSF National Quantum Virtual Laboratory - Quantum Testbeds
    Active
    National Science Foundation
    The National Science Foundation (NSF) is offering a grant opportunity titled "NSF National Quantum Virtual Laboratory - Quantum Testbeds," aimed at advancing quantum information science and technology. This initiative seeks proposals for the Design and Implementation phases of Quantum Science and Technology Demonstration (QSTD) projects, contingent upon prior successful Pilot and Design projects, respectively. The program is part of the National Quantum Initiative (NQI) Act, which emphasizes the importance of fostering early adoption of quantum technologies and engaging diverse stakeholders, including industry partners, to enhance research and development in this field. The estimated total funding for this program is $32 million, with proposals due by April 1, 2025. Interested applicants can reach out to NSF grants.gov support at grantsgovsupport@nsf.gov for assistance.